Acrux
Rights acquired to commercialize contraceptive spray
Published in Lab Law Weekly, March 10th, 2006
Under the agreement, Acrux has a worldwide license from the Population Council to intellectual property covering the use of Nestorone with Acrux's patented metered-dose skin spray delivery technology (MDTS). Acrux will develop and commercialize Nestorone MDTS and has the right to sublicense to commercial partners.
In addition to commercial distribution of the product, Acrux (or its sublicensees) will make Nestorone MDTS available at reduced...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2006-03-10)
More Articles from Lab Law Weekly
- AspenBio Pharma, Inc.
Appendicitis test-related patent published - Can-Fite BioPharma
Ilan Cohn named vice chairman of the board at Israeli pharmaceutical firm - Connetics Corp.
Dermatology company names Freddie Park vice president, intellectual property - Healthcare Costs
Hospital leaders urge lawmakers to reject proposals on charity care and billing - Medistem Laboratories, Inc.
Stem cell company licenses intellectual property to Institute for Cellular Medicine - Soonchunhyang University Bucheon Hospital
Smaller postprocedural minimal lumen diameter is linked to late recurrence in-stent restenosis - More from this issue of Lab Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
